This federal contract award, valued at $25,083.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DB25FU4CM) for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract is not set aside and has an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order worth $2,176.72 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a firm fixed price and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,879.70 firm fixed-price delivery order is for the supply of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 22, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a diabetes treatment medication, with a ceiling value of $2,448.81. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 29, 2025. The contract is not set-aside and is open to full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,779.03 delivery order contract is for the supply of Mounjaro 2.5 mg/0.5 mL pens, a medication used to treat diabetes. The contract has a firm fixed-price pricing type and an ultimate completion date of April 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,448.81 firm fixed-price delivery order is for the supply of MOUNJARO 7.5 mg/0.5 ml pens, a diabetes medication. The award, which has an ultimate completion date of November 21, 2024, is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,892.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This is a firm-fixed-price delivery order contract with a completion date of July 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded an...
This federal contract award, with a ceiling value of $1,263.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 12.5 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and an ultimate completion date of January 12, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,458.22 Firm Fixed Price Delivery Order is for the supply of Mounjaro 5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a completion date of November 22, 2024 and was awarded on November 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $13,740.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a diabetes treatment medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a period of performance through May 14, 2025. The contract is not set aside for any particular business type. As a large...